BISOPROLOL I KhRONIChESKAYa SERDEChNAYa NEDOSTATOChNOST'
- Authors: Kirichenko A.A1
-
Affiliations:
- Issue: No 9 (2014)
- Pages: 70-75
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/286976
- ID: 286976
Cite item
Abstract
Therapy with β-adrenergic receptor blockers leads to a decrease in the risk of death and serious cardiovascular complications in patients with chronic heart failure (CHF). Treatment with β-blockers has a particular significant effect on the risk of fatal ventricular arrhythmias in patients with high risk of sudden death. Bisoprolol is metabolically neutral and has good bioavailability, long half-life, and balanced clearance. High efficacy and good tolerability allows to consider this drug as one of the main medicines recommended for use in patients with CHF.
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
References
Supplementary files
![](/img/style/loading.gif)